News

Q:
I'd like to ask General Manager Jiang to first share the current growth and trends in the domestic and international mask markets. Why did you choose masks as the foundation for your startup, and what do you consider to be the most important and long-term competitive advantage in this market?

A:
ChenKang BioTech Co.,Ltd is a company that has been focusing on medical masks producing. The demand for masks in the market is stable and growing continuously. The reason why we established our business foundation on masks is because we understand their importance in medical and public health and hope to contribute to the country's epidemic prevention and control efforts.

ChenKang BioTech Co.,Ltd's long-term competitive advantages mainly include:

• Research development and innovation: We have self-developed technology innovations ,such as mask non-woven fabric support materials and technology films, which can improve the filtration efficiency and comfort of masks while increasing their ventilation space. In addition, we continue to innovate and develop products that to better meet market demands to and enhance our competitiveness.
• Quality assurance: We have both a comprehensive quality management system and professional quality testing equipment to ensure that every mask produced meets international standards and customer requirements. Our factory uses automated production equipment with an Industry 4.0 management system to avoid human error and ensure the consistency and stability of masks.
• Production capacity: We have a fully automated production line with a maximum monthly output of up to one million pieces, allowing us to quickly meet customer demand. Our factory's clean room facilities comply with sterile production standards, ensuring product hygiene and safety.

Q:
Why did Chien Kang Biotechnology decide to enter the European Union and UK markets with the FFP2 masks it produces? What preparations did you make in the process of entering the international market with your own brand?

A:
The mission of ChenKang BioTech Co.,Ltd. is to produce high-quality masks to protect people's health and safety. We believe that the EU and UK are crucial markets in the global mask industry, with high mask demands for mask quality and standards. Therefore, we aim to enter these markets and provide the local population with reliable and high-quality masks.

To enter the EU and UK markets, we have made the following preparations:

1. Obtained necessary certifications: Our masks have obtained BSI certifications in the EU and UK, which is one of the essential requirements to enter these markets.
2. Studied market demands and standards: We have carefully studied the mask market demands and standards in the EU and UK to ensure that our products can meet local regulations and requirements.
3. Optimized production processes: We have optimized our production processes and invested in automated production equipment and control systems to ensure production efficiency and quality.
4. Established brand image: We have established our own brand image and provide customized OBL brand certificate applications to meet customer needs.

In summary, we believe that entering the EU and UK markets is an excellent opportunity to expand our business and enhance our brand awareness. We have made sufficient preparations to ensure that our products can be successfully sold in these markets. Cheng Kang Biotech Co., Ltd. mainly produces surgical masks for medical personnel to perform operations safely.

Q:
At that time, why did you decide to engage BSI for verification of personal protective equipment? We would like to understand the motivation and focus behind this decision, as well as the most challenging aspects you encountered during the verification process.

A:
ChenKang BioTech Co.,Ltd has been committed to producing high-quality personal protective equipment and recognizes the importance of such equipment in protecting human health. Therefore, we sought independent third-party verification to ensure that our products meet international standards and regulations and provide customers with greater confidence and trust. We chose BSI as our verification agency because of their extensive experience and professional knowledge, which enables them to provide comprehensive verification services that ensure our products meet international standards and regulations. Our goal is to provide high-quality products that meet customers' needs and expectations for personal protective equipment, and through BSI verification, shows the quality and value of our products to the world.

The biggest challenge in obtaining verification is to ensure that our products meet BSI's rigorous standards and requirements. This requires a significant investment of time and resources to test and improve our products to ensure them can provide effective protection under different conditions. Given the special nature of personal protective equipment, it is also necessary to ensure that all production processes comply with BSI standards and requirements and that all products can be traced back to every detail in the raw materials and production processes. Through the hard work and continuous improvement of our team, we ultimately succeeded in obtaining BSI verification certification.

Q:
After obtaining the verification, what has been the most significant benefit for Chen Kang Biotechnology?

A:
After having obtained certifications from UK BSI and EU BSI, ChenKang Bio-Tech Co., Ltd. has got greatly benefited from improved product credibility and market competitiveness. Certification signifies that the products meet international standards and requirements and have reliable quality and performance, which helps to attract more customers and expand increase market share. In addition, certification process also helps to improve production efficiency and quality control, promoting long-term and stable development of the company. ChenKang Bio-Tech can also assist its clients in applying for BSI OBL brand certification through certification, further expanding its business scope and market influence.